Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Anic, Gabriella M ^a   Weinstein, Stephanie J ^a   Mondul, Alison M ^a   Männistö, Satu ^b   Albanes, Demetrius ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALPHA TOCOPHEROL; BETA CAROTENE; CHOLESTEROL; RETINOL; VITAMIN D BINDING PROTEIN; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING HABIT; VITAMIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; BLOOD; COLORECTAL NEOPLASMS; DOUBLE BLIND PROCEDURE; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RISK; RISK FACTOR; STATISTICAL MODEL;

ALPHA-TOCOPHEROL; BETA CAROTENE; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DOUBLE-BLIND METHOD; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RISK; RISK FACTORS; VITAMIN D; VITAMIN D-BINDING PROTEIN;

EID: 84904470085     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102966     Document Type: Article

References (49)

1. Hansen CM, Binderup L, Hamberg KJ, Carlberg C (2001) Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis. Front Biosci 6: D820-848.
2. Deluca HF, Cantorna MT (2001) Vitamin D: its role and uses in immunology. FASEB J 15: 2579-2585. (Pubitemid 33131084)
3. Holick MF (2009) Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 19: 73-78.
4. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, et al. (2001) Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 86: 888-894. (Pubitemid 32207511)
5. Tangpricha V, Flanagan JN, Whitlatch LW, Tseng CC, Chen TC, et al. (2001) 25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet 357: 1673-1674. (Pubitemid 32568244)
6. Palmer HG, Gonzalez-Sancho JM, Espada J, Berciano MT, Puig I, et al. (2001) Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 154: 369-387. (Pubitemid 34286147)
7. Holt PR, Arber N, Halmos B, Forde K, Kissileff H, et al. (2002) Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D. Cancer Epidemiol Biomarkers Prev 11: 113-119. (Pubitemid 34118320)
8. Ma Y, Zhang P, Wang F, Yang J, Liu Z, et al. (2011) Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol 29: 3775-3782.
9. Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, et al. (2011) Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 128: 1414-1424.
10. Touvier M, Chan DS, Lau R, Aune D, Vieira R, et al. (2011) Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 20: 1003-1016.
11. Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA (2011) Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med 155: 827-838.
12. Weinstein SJ, Yu K, Horst RL, Ashby J, Virtamo J, et al. (2011) Serum 25-hydroxyvitamin D and risks of colon and rectal cancer in Finnish men. Am J Epidemiol 173: 499-508.
13. Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, et al. (2006) Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 354: 684-696. (Pubitemid 43247139)
14. Trivedi DP, Doll R, Khaw KT (2003) Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326: 469.
15. Hiraki LT, Qu C, Hutter CM, Baron JA, Berndt SI, et al. (2013) Genetic predictors of circulating 25-hydroxyvitamin d and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 22: 2037-2046.
16. Speeckaert M, Huang G, Delanghe JR, Taes YE (2006) Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta 372: 33-42. (Pubitemid 44286753)
17. Chun RF (2012) New perspectives on the vitamin D binding protein. Cell Biochem Funct 30: 445-456.
18. Chishimba L, Thickett DR, Stockley RA, Wood AM (2010) The vitamin D axis in the lung: a key role for vitamin D-binding protein. Thorax 65: 456-462.
19. Nagasawa H, Uto Y, Sasaki H, Okamura N, Murakami A, et al. (2005) Gc protein (vitamin D-binding protein): Gc genotyping and GcMAF precursor activity. Anticancer Res 25: 3689-3695. (Pubitemid 41658440)
20. Haddad JG (1995) Plasma vitamin D-binding protein (Gc-globulin): multiple tasks. J Steroid Biochem Mol Biol 53: 579-582.
21. Malik S, Fu L, Juras DJ, Karmali M, Wong BY, et al. (2013) Common variants of the vitamin D binding protein gene and adverse health outcomes. Crit Rev Clin Lab Sci 50: 1-22.
22. Weinstein SJ, Stolzenberg-Solomon RZ, Kopp W, Rager H, Virtamo J, et al. (2012) Impact of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin D and pancreatic cancer risk: a nested case-control study. Cancer Res 72: 1190-1198.
23. Weinstein SJ, Mondul AM, Kopp W, Rager H, Virtamo J, et al. (2013) Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer. Int J Cancer 132: 2940-2947.
24. Mondul AM, Weinstein SJ, Virtamo J, Albanes D (2012) Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer. Br J Cancer 107: 1589-1594.
25. Mondul AM, Weinstein SJ, Moy KA, Mannisto S, Albanes D (2014) Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma. Int J Cancer 134: 2699-2706.
26. The ATBC Cancer Prevention Study Group (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 330: 1029-1035.
27. Korhonen P, Malila N, Pukkala E, Teppo L, Albanes D, et al. (2002) The Finnish Cancer Registry as follow-up source of a large trial cohort-accuracy and delay. Acta Oncol 41: 381-388.
28. Pietinen P, Hartman AM, Haapa E, Rasanen L, Haapakoski J, et al. (1988) Reproducibility and validity of dietary assessment instruments. I. A self-administered food use questionnaire with a portion size picture booklet. Am J Epidemiol 128: 655-666.
29. Reinivuo H, Hirvonen T, Ovaskainen ML, Korhonen T, Valsta LM (2010) Dietary survey methodology of FINDIET 2007 with a risk assessment perspective. Public Health Nutr 13: 915-919.
30. Ersfeld DL, Rao DS, Body JJ, Sackrison JL Jr, Miller AB, et al. (2004) Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. Clin Biochem 37: 867-874. (Pubitemid 39209026)
31. Gallicchio L, Helzlsouer KJ, Chow WH, Freedman DM, Hankinson SE, et al. (2010) Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 172: 10-20.
32. Material Measurement Laboratory (2009) (http://www.nist.gov/mml/csd/ vitamind-071409.cfm) Certificate of Analysis.Standard Reference Material 972. Vitamin D in Human Serum. National Institute of Standards and Technology.
33. Fears TR, Ziegler RG, Donaldson JL, Falk RT, Hoover RN, et al. (2000) Reproducibility studies and interlaboratory concordance for androgen assays in female plasma. Cancer Epidemiol Biomarkers Prev 9: 403-412. (Pubitemid 30265784)
34. Bouillon R, Van Assche FA, Van Baelen H, Heyns W, De Moor P (1981) Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration. J Clin Invest 67: 589-596. (Pubitemid 11142347)
35. Al-oanzi ZH, Tuck SP, Raj N, Harrop JS, Summers GD, et al. (2006) Assessment of vitamin D status in male osteoporosis. Clin Chem 52: 248-254. (Pubitemid 43185486)
36. Matsunawa M, Amano Y, Endo K, Uno S, Sakaki T, et al. (2009) The aryl hydrocarbon receptor activator benzo[a]pyrene enhances vitamin D3 catabolism in macrophages. Toxicol Sci 109: 50-58.
37. Brown AJ, Coyne DW (2012) Bioavailable vitamin D in chronic kidney disease. Kidney Int 82: 5-7.
38. Gregory KJ, Zhao B, Bielenberg DR, Dridi S, Wu J, et al. (2010) Vitamin D binding protein-macrophage activating factor directly inhibits proliferation, migration, and uPAR expression of prostate cancer cells. PLoS One 5: e13428.
39. Nykjaer A, Dragun D, Walther D, Vorum H, Jacobsen C, et al. (1999) An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96: 507-515. (Pubitemid 29106838)
40. Ternes SB, Rowling MJ (2013) Vitamin d transport proteins megalin and disabled-2 are expressed in prostate and colon epithelial cells and are induced and activated by all-trans-retinoic acid. Nutr Cancer 65: 900-907.
41. Andreassen TK (2006) The role of plasma-binding proteins in the cellular uptake of lipophilic vitamins and steroids. Horm Metab Res 38: 279-290.
42. Lin JH, Zhang SM, Rexrode KM, Manson JE, Chan AT, et al. (2013) Association between sex hormones and colorectal cancer risk in men and women. Clin Gastroenterol Hepatol 11: 419-424 e411.
43. Wu WK, Wong HP, Luo SW, Chan K, Huang FY, et al. (2005) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone from cigarette smoke stimulates colon cancer growth via beta-adrenoceptors. Cancer Res 65: 5272-5277. (Pubitemid 40827338)
44. Wei PL, Chang YJ, Ho YS, Lee CH, Yang YY, et al. (2009) Tobacco-specific carcinogen enhances colon cancer cell migration through alpha7-nicotinic acetylcholine receptor. Ann Surg 249: 978-985.
45. Corder EH, Friedman GD, Vogelman JH, Orentreich N (1995) Seasonal variation in vitamin D, vitamin D-binding protein, and dehydroepiandrosterone: risk of prostate cancer in black and white men. Cancer Epidemiol Biomarkers Prev 4: 655-659.
46. Gann PH, Ma J, Hennekens CH, Hollis BW, Haddad JG, et al. (1996) Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomarkers Prev 5: 121-126.
47. Sonderman JS, Munro HM, Blot WJ, Signorello LB (2012) Reproducibility of serum 25-hydroxyvitamin d and vitamin D-binding protein levels over time in a prospective cohort study of black and white adults. Am J Epidemiol 176: 615-621.
48. Hofmann JN, Yu K, Horst RL, Hayes RB, Purdue MP (2010) Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev 19: 927-931.
49. Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, et al. (2010) Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol 171: 903-908.